In the three remaining Dravet syndrome patients without SCN1A mutations, additional proconvulsive genes that act in concert with SCN9A may yet be uncovered. The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.